Ozempic, Wegovy Among 15 Drugs Selected by HHS for Medicare Price Negotiations

The Epoch Times Header

The department said the drugs are relied upon by millions to treat conditions including asthma, cancer and diabetes.

The U.S. Department of Health and Human Services (HHS) said on Jan. 17 that it has selected the next 15 drugs to undergo Medicare drug price negotiations with pharmaceutical companies, as the federal government seeks to lower soaring medical costs for Americans.

The drugs are relied upon by millions of seniors across the country to treat an array of conditions such as asthma, cancer, and diabetes, and accounted for roughly $41 billion in total gross covered prescription drug costs under Medicare Part D between Nov. 1, 2023, and Oct. 31, 2024, HHS said.

They include popular drugs Ozempic and Wegovy, which are used for diabetes and weight loss, as well as cancer medications Ibrance and Xtandi.

According to HHS, negotiations with participating drug companies will take place in 2025, with any negotiated prices going into effect for people with Medicare Part D prescription drug coverage in 2027.

Negotiations will be led by the Centers for Medicare & Medicaid Services (CMS).

The latest negotiations are made possible by the Inflation Reduction Act, signed into law in 2022, which gave Medicare the power to negotiate prescription drug prices with pharmaceutical companies.

Medicare covers around 66 million people across the nation.

“Last year we proved that negotiating for lower drug prices works,” said HHS Secretary Xavier Becerra. “Now we plan to build on that record by negotiating for lower prices for 15 additional important drugs for seniors.”

Becerra said HHS will “continue negotiating in the best interest of people with Medicare to have access to innovative, life-saving treatments at lower costs.”

The drugs up for negotiation are:

  • Ozempic, Rybelsus, Wegovy: Used for weight loss and to treat Type 2 diabetes.
  • Trelegy Ellipta: An asthma treatment.
  • Xtandi: Used for prostate cancer.
  • Pomalyst: A chemotherapy drug used for Kaposi’s sarcoma and multiple myeloma.
  • Ibrance: A breast cancer drug.
  • Ofev: Used for idiopathic pulmonary fibrosis.
  • Linzess: Used to treat chronic constipation and irritable bowel syndrome with constipation.
  • Calquence: A cancer drug used in the treatment of chronic lymphocytic leukemia and mantle cell lymphoma.
  • Austedo, Austedo XR: Used for Huntington’s disease and tardive dyskinesia.
  • Breo Ellipta: A chronic obstructive pulmonary disease and asthma drug.
  • Tradjenta: Used to treat Type 2 diabetes.
  • Xifaxan: Used for diarrhea and irritable bowel syndrome.
  • Vraylar: An antipsychotic drug used to treat bipolar I disorder, major depressive disorder, and schizophrenia.
  • Janumet, Janumet XR: Diabetes drugs.
  • Otezla: Used for oral ulcers in Behçet’s disease, plaque psoriasis, and psoriatic arthritis.

By Katabella Roberts

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Columns

 Are Democrats Synonymous with Treason and Sedition?

Conservative Americans on social media platforms are seeing lists Democrats and groups they would like to see brought up on charges of treason and sedition.

“We The People”  vs “We The Elites” (The Choice Europe Is Destined to Make)

Europe faces a choice—to break the rule of the elites, who are dragging it towards economic and civilizational catastrophe or to return to freedom, common sense, and Rule of the People.

Trump’s Tariffs: Restoring America’s Economic Might

Trump’s tariff policy is a declaration of American grit, a refusal to let the nation’s destiny be dictated by foreign factories and globalist elites.

Florida Passes a Bill to Stop Weather Manipulation

Florida State Senate passed a bill “SB 56 Geoengineering and Weather Modification Activities” to ban weather modification in and around state.

The Proxy War – That Wasn’t

Britain, Europe and Biden Admin put us at risk of major conflict over past 3 years with self-serving political agenda and leadership away from geopolitical stability.

News

Helicopter Crashes in the Hudson River Near Manhattan

Videos posted to social media showed the helicopter mostly...

RFK Jr. Says US Is Launching Massive Effort to Pinpoint Cause of Spiking Autism Rates

Health Secretary RFK Jr. said the United States has started a “massive” new effort to learn what has caused autism rates to spike in recent years.

RFK Jr. Says Food Companies Have 2 Years to Remove Artificial Dyes

Health Sec RFK Jr. said that he has given food company executives two years to remove Red 40 and other artificial dyes from their products.

USPS Seeks to Raise Stamp Price to 78 Cents to Achieve Financial Stability

USPS said it is seeking to raise the price of first-class forever stamps from 73 cents to 78 cents, an increase aimed at achieving financial stability.

US Stocks Drop Day After Trump Tariff Pause Announcement

Wall Street opened sharply lower on Thursday morning, coming a day after Trump’s said he would pause reciprocal tariffs for every country except China.

Global Markets Rally After Trump Pauses Tariffs

Stocks surged after Trump announced 90-day pause on reciprocal tariffs for many trading partners, prompting rally following a days-long market rout.

Federal Government Moves to Drop Case Against Alleged MS-13 Gang Leader

Federal prosecutors are seeking to drop a criminal case against an illegal immigrant the DOJ accused of being a leader of the MS-13 gang following his arrest.

Inflation Slows Sharply to 2.4 Percent, Lowest in Half a Year

According to the Bureau of Labor Statistics, the annual inflation rate declined to 2.4% from 2.8% in February, the lowest reading since September.
spot_img

Related Articles

Popular Categories

MAGA Business Central